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Transient NADH Responses to Cyanide Related to the Absorption Proper-
ties of Intact Cardiac Tissue
Iffath A. Ghouri, Ole J. Kemi, Aileen Rankin, Godfrey L. Smith.
Measurements of the intrinsically fluorescent metabolite NADH can be used to
monitor mitochondrial redox state in isolated cardiomyocytes. NADH was 2P
excited at 720nm and fluorescence was collected at 435-485nm. Calibration of
the fluorescence signal with the metabolic inhibitors FCCP and cyanide en-
abled establishment of mitochondrial redox state. Treatment with 2mM FCCP
induces maximally oxidised mitochondrial states, causing NADH fluorescence
to decrease to minimal levels. Conversely, treatment with 2mM cyanide in-
duces maximally reduced mitochondrial states, resulting in NADH fluores-
cence increasing to maximal levels.
Similar measurements were performed in a Langendorff perfused whole heart
preparation. However, unlike with isolated cells, the cyanide response was tran-
sient in nature. A possible reason for this could be the influence of inner-filter
effects in thick tissue preparations. Investigation into the effects of cyanide on
tissue transmission properties was carried out using a blue LED with 450-
490nm emission (corresponding to NADH emission). Cyanide perfusion
caused light transmission at these wavelengths to decrease in the left ventricle
(LV), but increase in the right ventricle (RV). The most likely sources of ab-
sorption at these wavelengths are from myoglobin and FAD (oxidised). Spec-
troscopic examination revealed that light absorption by myoglobin at
wavelengths corresponding to NADH emission increased upon cyanide appli-
cation (due to binding of cyanide to myoglobin). FAD absorption decreased
when reduced to FADH2, mimicking the effects of cyanide on mitochondrial
FAD in the tissue. Thus, the additional complications caused by inner-filter ef-
fects and other optical artefacts may explain the transient NADH response to
cyanide observed in our intact tissue preparations. The balance between myo-
globin and FAD concentrations are likely to explain the differing transmission
responses to cyanide in the LV and RV, with LV tissue containing more
myoglobin.
1594-Pos Board B504
Drosophila as a Model for Amyloid Induced Cardiac Dysfunction
Girish C. Melkani, Karen Ocorr, Rolf Bodmer, Sanford I. Bernstein.
Several human diseases are associated with the expression of mutated, mis-
folded and aggregation-prone amyloid proteins. Huntington’s disease (HD) is
caused by mutation in the Huntingtin protein that results in an expanded poly-
glutamine (PQ) repeat and formation of amyloid-like inclusions. The length of
the PQ-repeat is also important in the progression of disease. Recent evidence
indicates that patients with HD demonstrate a greater occurrence of cardiovas-
cular events but very little is known as to how HD leads to cardiac failure. Our
study uses the model organism Drosophila melanogaster to explore PQ
amyloid-induced cardiac dysfunction. Using the UAS-Gal4 expression system,
we express short and long UAS-PQ in the Drosophila heart using a cardiac spe-
cific driver (Hand-Gal4). Expression of extended PQ (UAS-97Q) resulted in
severe cardiac defects. However, no such defects were seen upon expression
of short PQ (UAS-25Q) under similar conditions. For example, the arrhythmic-
ity index (overall measure of cardiac arrhythmia) of 1 week old PQ-97 fly
hearts was twice that of the same age flies expressing PQ-25. Further, more
progressive cardiac dysfunction (six fold increase in arrhythmicity index)
was observed after 3 weeks in fly hearts expressing PQ-97 compared to same
age fly hearts expressing PQ-25. Additionally, heart period, diastolic and sys-
tolic intervals of 1 and 3 week old fly hearts expressing PQ-97 were higher
compared to same age flies expressing PQ25. Our results show that expression
of PQ-97 causes progressive cardiac dysfunction. We are currently examining
structural defects and possible amyloid aggregates in the cardiac tube that
arises upon expression of extended PQ. Our study organism Drosophila, with
its high degree of conservation relative to the human genome and many tech-
niques to manipulate its gene expression, will be an excellent model for under-
standing the mechanism of cardiac failure in HD patients.
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Altered Force Development in Response to Calcium and Isopreterenol
in Cardiac Muscle from Gravin Knock-Out (AKAP12) Mice
Wei Dong Gao, Zhitao Li, Cori Wijaya, Bradley K. McConnell.
Gravin (AKAP12), one of the A-Kinase-Binding-Proteins (AKAPs), serves as
a scaffold protein linking b2-adrenergic receptor (b2-AR), phosphatase 2B and
several kinases including Protein Kinase A (PKA) and Protein Kinase C (PKC).
The presence of gravin facilitates signal transduction of b2-AR and thus affects
cardiac excitation-contraction coupling. Here, we test whether cardiac contrac-
tion is also affected in gravin knock-out (gravin-KO) mice. Trabeculae or smallpapillary muscles from the right ventricles were mounted between a force trans-
ducer and a motor arm, and superfused with K-H solution (pH 7.4) at room tem-
perature. Developed force increased as external Ca2þ ([Ca2þ]o) was raised from
1 to 10 mmol/L in both gravin-KO and widetype (WT) muscles. Developed
force increased in a dose dependent manner as [Ca2þ]o was raised. In gravin-
KO muscles, lower [Ca2þ]o (>3.0 mmol/L) caused higher but insignificant
force development as compared with WT muscles. At higher [Ca2þ]os, devel-
oped forces remained largely flat and significantly lower in gravin-KO muscles
as [Ca2þ]o was increased up to 10.0 mmol/L. Similarly, developed force in-
creased as doses of isopreterenol (ISO) increased (0.05 nmol/L to 200 nmol/
L) in both groups of muscles. However, force response started to blunt in
gravin-KO muscle at ISO doses >5 nmol/L and became significantly lower
at ISO does >50 nmol/L. These results show that gravin-KO muscles maintain
their response to both Ca2þ and ISO, with reduced capacity at higher doses,
suggesting that gravin plays an important modulatory role in the argumentation
of force by Ca2þ and b2-AR stimulation. Ongoing experiments are focused on
changes in intracellular Ca2þ and myofilament Ca2þ responsiveness in gravin-
KO mice.
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Gsk Mediates Rapid Estrogen-Induced Cardioprotection Without Akt
Activation After Ischemia/Reperfusion
Jean Chrisostome Bopassa, Harpreet Singh, Ligia Toro, Enrico Stefani.
We investigated the role of Glycogen Synthase Kinase (GSK-3b), Erk and Akt
activation in rapid 17ß-estradiol (E2)-induced cardioprotection after ischemia/
reperfusion.
Isolated mice hearts were retrograde-perfused using the Langendorff system at
37oC. Hearts were perfused with oxygenated (95% O2 and 5% CO2) Krebs
Henseleit solution (control) or with E2 (40 nM). After 20 min perfusion, hearts
were subjected to 20 min global normothermic ischemia followed by 40 min
reperfusion. Cardiac function was recorded throughout the experiment and at
the end of the reperfusion (60 min) infarct size was evaluated by TTC staining.
After 10 min of reperfusion, mitochondria were isolated to assess the calcium
load required to induce the opening of mitochondria permeability transition
pore (mPTP) referred as Calcium Retention Capacity (CRC), and whole heart
lysates were prepared for Western blot analysis of pGSK-3b, pErk, pAkt and
vinculin.
The E2-treated group had significantly increased CRC (287517 vs. 180512
nM/mg mitochondrial protein p<0.05), reduced infarct size (2653% vs.
5452.8% p<0.001) and improved heart functional recovery (RPP,
119005467 vs. 59115318 mmHgxbeats/min, p<0.001) when compared to
control. GSK-3b and Erk1/2 phosphorylation levels were significantly in-
creased in E2-treated hearts (~3 and ~2 fold, respectively) without significant
changes in Akt phosphorylation. These results indicate that rapid E2-induced
cardioprotection inhibits the mPTP opening resulting in a reduction of the in-
farct size and improvement of heart function recovery via GSK-3b and Erk
phosphorylation independently of Akt phosphorylation. Supported by NIH.
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Loss of Rapid Estrogen-Induced Cardioprotection in GPER-/- Mice After
Ischemia and Reperfusion
Jean Chrisostome Bopassa, L.M. Frederik Leeb-Lundberg, Bjo¨rn Olde,
Ligia Toro, Enrico Stefani.
Several studies have demonstrated that G protein coupled receptor 30
(GPER) can directly bind to 17ß-estradiol (E2) mediating its action. Using
pharmacological tools, we previously identified GPER as possible mediator
of E2-mediated cardioprotection in male wild type (WT) mice subjected to is-
chemia/reperfusion. Here, we investigate this point further using GPER-/-
mice.Isolated hearts from male WT (C57BL/6NCrL) or GPER-/- mice were
perfused using the Langendorff technique with oxygenated (95% O2 and 5%
CO2) Krebs Henseleit buffer (control) containing or not 40 nM E2. After 20
min of perfusion, hearts were subjected to 18 min global normothermic ische-
mia followed by 60 min reperfusion. Heart function was continuously recorded
and myocardial necrosis was evaluated by TTC staining after the reperfusion.
Mitochondria were isolated after 10 minutes of reperfusion to assess the cal-
cium load required to induce opening of mitochondria permeability transition
pore referred as Calcium Retention Capacity (CRC). In WT mice, E2 treatment
induced a much better recovery of heart function when compared with un-
treated hearts (RPP, 119005467 vs. 59115318 mmHgxbeats/min,
p<0.001). In contrast, E2 treatment had no beneficial action in GPER-/-
mice. No functional differences between E2-treated and control were found
(RPP, 63705655 vs. 62005380 mmHgxbeats/min). Similarly, the infarct
size decreased significantly in WT hearts after E2-treatment (2653% vs.
5452.8% p<0.001) but this protective infarct reduction by E2 treatment was
not observed in GPER-/- hearts (4655% vs. 5054%). A similar pattern was
found with CRC. E2 treatment in WT hearts significantly increased the
